Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 105214, 8 pages
http://dx.doi.org/10.1155/2014/105214
Research Article

Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats

1Department of Pharmacology, Faculty of Medicine, Minia University, El-Minia 61511, Egypt
2Department of Histology, Faculty of Medicine, Minia University, El-Minia 61511, Egypt
3Department of Physiology, Faculty of Medicine, Minia University, El-Minia 61511, Egypt

Received 27 February 2014; Revised 15 May 2014; Accepted 21 May 2014; Published 4 June 2014

Academic Editor: Youhua Liu

Copyright © 2014 Mohamed A. Morsy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Forbes, K. Fukami, and M. E. Cooper, “Diabetic nephropathy: where hemodynamics meets metabolism,” Experimental and Clinical Endocrinology and Diabetes, vol. 115, no. 2, pp. 69–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Drummond and M. Mauer, “The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes,” Diabetes, vol. 51, no. 5, pp. 1580–1587, 2002. View at Google Scholar · View at Scopus
  3. R. C. Wiggins, “The spectrum of podocytopathies: a unifying view of glomerular diseases,” Kidney International, vol. 71, no. 12, pp. 1205–1214, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Niedowicz and D. L. Daleke, “The role of oxidative stress in diabetic complications,” Cell Biochemistry and Biophysics, vol. 43, no. 2, pp. 289–330, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. F. Navarro-González and C. Mora-Fernández, “The role of inflammatory cytokines in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 19, no. 3, pp. 433–442, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. H. H. Arab and M. M. El-Sawalhi, “Carvedilol alleviates adjuvant-induced arthritis and subcutaneous air pouch edema: modulation of oxidative stress and inflammatory mediators,” Toxicology and Applied Pharmacology, vol. 268, no. 2, pp. 241–248, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Yasar, F. Erdemir, B. S. Parlaktas et al., “The effect of carvedilol on serum and tissue oxidative stress parameters in partial ureteral obstruction induced rat model,” Kaohsiung Journal of Medical Sciences, vol. 29, no. 1, pp. 19–25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. K. V. Kumar, A. A. Shifow, M. U. R. Naidu, and K. S. Ratnakar, “Carvedilol: a beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats,” Life Sciences, vol. 66, no. 26, pp. 2603–2611, 2000. View at Google Scholar · View at Scopus
  9. M. A. C. Rodrigues, J. L. Rodrigues, N. M. Martins et al., “Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria,” Chemico-Biological Interactions, vol. 189, no. 1-2, pp. 45–51, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Hayashi, M. A. De Velasco, Y. Saitou et al., “Carvedilol protects tubular epithelial cells from ischemia-reperfusion injury by inhibiting oxidative stress,” International Journal of Urology, vol. 17, no. 12, pp. 989–995, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Honoré, W. M. Cabrera, S. B. Genta, and S. S. Sánchez, “Protective effect of yacon leaves decoction against early nephropathy in experimental diabetic rats,” Food and Chemical Toxicology, vol. 50, no. 5, pp. 1704–1715, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. G.-S. Fu, H. Huang, F. Chen et al., “Carvedilol ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats,” European Journal of Pharmacology, vol. 567, no. 3, pp. 223–230, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Buege and S. D. Aust, “Microsomal lipid peroxidation,” Methods in Enzymology, vol. 52, no. C, pp. 302–310, 1978. View at Publisher · View at Google Scholar · View at Scopus
  14. K. V. H. Sastry, R. P. Moudgal, J. Mohan, J. S. Tyagi, and G. S. Rao, “Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy,” Analytical Biochemistry, vol. 306, no. 1, pp. 79–82, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. P. D. Hart and G. L. Bakris, “Should β-blockers be used to control hypertension in people with chronic kidney disease?” Seminars in Nephrology, vol. 27, no. 5, pp. 555–564, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. G. L. Bakris, V. Fonseca, R. E. Katholi et al., “Differential effects of β-blockers on albuminuria in patients with type 2 diabetes,” Hypertension, vol. 46, no. 6, pp. 1309–1315, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Jawa, S. Nachimuthu, M. Pendergrass, S. Asnani, and V. Fonseca, “Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension,” Journal of Diabetes and Its Complications, vol. 22, no. 5, pp. 303–308, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. L. L. Dugan, Y. H. You, S. S. Ali et al., “AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function,” The Journal of Clinical Investigation, vol. 123, no. 11, pp. 4888–4899, 2013. View at Google Scholar
  19. D. Singh, V. Chander, and K. Chopra, “Carvedilol attenuates ischemia-reperfusion-induced oxidative renal injury in rats,” Fundamental and Clinical Pharmacology, vol. 18, no. 6, pp. 627–634, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Franco, O. J. Schoneveld, A. Pappa, and M. I. Panayiotidis, “The central role of glutathione in the pathophysiology of human diseases,” Archives of Physiology and Biochemistry, vol. 113, no. 4-5, pp. 234–258, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Oettl, J. Greilberger, K. Zangger, E. Haslinger, G. Reibnegger, and G. Jürgens, “Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity,” Biochemical Pharmacology, vol. 62, no. 2, pp. 241–248, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. J. S. Christo, A. M. Rodrigues, M. G. Mouro et al., “Nitric oxide (NO) is associated with gentamicin (GENTA) nephrotoxicity and the renal function recovery after suspension of GENTA treatment in rats,” Nitric Oxide—Biology and Chemistry, vol. 24, no. 2, pp. 77–83, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. L. M. Walker, P. D. Walker, S. Z. Imam, S. F. Ali, and P. R. Mayeux, “Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N6-(1-iminoethyl)lysine,” Journal of Pharmacology and Experimental Therapeutics, vol. 295, no. 1, pp. 417–422, 2000. View at Google Scholar · View at Scopus
  24. G. Wolf, S. Chen, and F. N. Ziyadeh, “From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy,” Diabetes, vol. 54, no. 6, pp. 1626–1634, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J. F. Reckelhoff, V. L. Tygart, M. M. Mitias, and J. L. Walcott, “STZ-induced diabetes results in decreased activity of glomerular cathepsin and metalloprotease in rats,” Diabetes, vol. 42, no. 10, pp. 1425–1432, 1993. View at Google Scholar · View at Scopus
  26. K. Wu, S. Setty, S. M. Mauer et al., “Altered kidney matrix gene expression in early stages of experimental diabetes,” Acta Anatomica, vol. 158, no. 3, pp. 155–165, 1997. View at Google Scholar · View at Scopus
  27. M. L. Caramori, Y. Kim, C. Huang et al., “Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes,” Diabetes, vol. 51, no. 2, pp. 506–513, 2002. View at Google Scholar
  28. S. Hoshi, Y. Shu, F. Yoshida et al., “Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats,” Laboratory Investigation, vol. 82, no. 1, pp. 25–35, 2002. View at Google Scholar · View at Scopus